Judith Anna Catharina Rietjens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Judith Anna Catharina Rietjens has a total of 318 co-authors. Here are the top co-authors by number of shared publications:
- Agnes van der Heide
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
25 shared publications Agnes van der Heide
Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
22 shared publications- Ida Joanna Korfage
Erasmus Medical Centre, Rotterdam, The Netherlands
18 shared publications - Johannes J. M. van Delden
Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
10 shared publications - Luc Deliens
End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Ghent, Belgium
7 shared publications - Doris van der Smissen
Tilburg University
6 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by MDPI AG in Health Economics and Policy
- Vol. 1 (2) , 12
Study Protocol for a Cost-Effectiveness Analysis Along a Pre-Test–Post-Test Study Evaluating the Application of Metro Mapping in Clinical Care Paths of Patients with Breast Cancer, Prostate Cancer, and Melanoma in Denmark, The Netherlands, and Spain
Background: Metro Mapping is an innovative service design methodology to co-design clinical care paths to support shared decision-making in oncology. We provide a study protocol for a cost-effectiveness analysis (CEA) evaluating health effects and costs of applying Metro Mapping to redesign selected clinical care paths for patients with cancer. Methods: The CEA will be conducted alongside a pre-test–post-test study evaluating the impact of Metro Mapping on decision-making processes and outcomes in selected clinical care paths of patients with melanoma, breast, or prostate cancer in the Netherlands, Denmark, and Spain. In the pre-test phase, patients follow the standard cancer treatment path. In the post-test phase, patients follow a care path redesigned using Metro Mapping. In the CEA, care after Metro Mapping (i.e., post-test) will be evaluated against care before Metro Mapping (i.e., the pre-test). The CEA adopts a societal perspective; health effects and costs will be evaluated alongside selected care paths in both pre- and post-test groups over a time horizon of 36 months corresponding to the study period. Regret after a healthcare decision based on the decision regret scale (inversely reflecting satisfaction) and health-related quality of life based on EQ-5D-5L and EORTC QLU-C10D will be assessed at the beginning and after six months for each care trajectory, in both groups. Direct medical costs will be estimated using resource utilization from electronic medical records and reimbursement prices. Direct non-medical costs and indirect costs will be assessed through a short version of the iMTA Productivity Cost Questionnaire employed at the end of each care trajectory. Main outcomes are absolute total costs, quality-adjusted life years, decision regret/satisfaction, and the incremental cost-effectiveness ratio for the application of Metro Mapping vs. no Metro Mapping. Health effects and costs will be evaluated using descriptive statistics and multivariable statistical methods to account for baseline confounding. Uncertainty will be assessed through deterministic and probabilistic sensitivity analyses. Discussion: This study protocol describes a prospective and systematic CEA alongside a pre-test–post-test study to evaluate the cost-effectiveness of Metro Mapping in selected care paths of three different cancers and countries, making the research process transparent and reproducible. Trial registration: The pre-test–post-test study has been registered in the clinical.gov trial registry (record number: 8423, identifier: NCT06685562, registration date: 12 November 2024).
- 19 November 2026
- Published by MDPI AG in Health Economics and Policy
- Vol. 1 (2) , 12
Open AccessStudy Protocol for a Cost-Effectiveness Analysis Along a Pre-Test–Post-Test Study Evaluating the Application of Metro Mapping in Clinical Care Paths of Patients with Breast Cancer, Prostate Cancer, and Melanoma in Denmark, The Netherlands, and Spain
Background: Metro Mapping is an innovative service design methodology to co-design clinical care paths to support shared decision-making in oncology. We provide a study protocol for a cost-effectiveness analysis (CEA) evaluating health effects and costs of applying Metro Mapping to redesign selected clinical care paths for patients with cancer. Methods: The CEA will be conducted alongside a pre-test–post-test study evaluating the impact of Metro Mapping on decision-making processes and outcomes in selected clinical care paths of patients with melanoma, breast, or prostate cancer in the Netherlands, Denmark, and Spain. In the pre-test phase, patients follow the standard cancer treatment path. In the post-test phase, patients follow a care path redesigned using Metro Mapping. In the CEA, care after Metro Mapping (i.e., post-test) will be evaluated against care before Metro Mapping (i.e., the pre-test). The CEA adopts a societal perspective; health effects and costs will be evaluated alongside selected care paths in both pre- and post-test groups over a time horizon of 36 months corresponding to the study period. Regret after a healthcare decision based on the decision regret scale (inversely reflecting satisfaction) and health-related quality of life based on EQ-5D-5L and EORTC QLU-C10D will be assessed at the beginning and after six months for each care trajectory, in both groups. Direct medical costs will be estimated using resource utilization from electronic medical records and reimbursement prices. Direct non-medical costs and indirect costs will be assessed through a short version of the iMTA Productivity Cost Questionnaire employed at the end of each care trajectory. Main outcomes are absolute total costs, quality-adjusted life years, decision regret/satisfaction, and the incremental cost-effectiveness ratio for the application of Metro Mapping vs. no Metro Mapping. Health effects and costs will be evaluated using descriptive statistics and multivariable statistical methods to account for baseline confounding. Uncertainty will be assessed through deterministic and probabilistic sensitivity analyses. Discussion: This study protocol describes a prospective and systematic CEA alongside a pre-test–post-test study to evaluate the cost-effectiveness of Metro Mapping in selected care paths of three different cancers and countries, making the research process transparent and reproducible. Trial registration: The pre-test–post-test study has been registered in the clinical.gov trial registry (record number: 8423, identifier: NCT06685562, registration date: 12 November 2024).
- Open Access
- 1 September 2026
- Published by Elsevier in SSRN Electronic Journal
Understanding cancer patients’ preferred and experienced modes of information provision and decisional roles: a cross-sectional questionnaire study in seven European countries
Objectives: Shared Decision Making (SDM) in oncology relies on clear information provision and concordance between patients’ preferred and experienced decisional roles. This study examined preferred and experienced modes of information provision and decisional roles, and assessed whether these varied patients’ by country, cancer type, and sociodemographic characteristics.Methods: A cross-sectional digital survey was conducted among 2,508 respondents with cancer across seven European countries. Modes of information provision were assessed, and decisional roles were measured using the Control Preferences Scale (active, collaborative, passive role). Analyses included chi-square tests, weighted kappa, and multinomial logistic regression.Results: Overall, 69% of respondents reported having been informed about treatment options, ranging from 36% in Sweden to 95% in the UK. Face-to-face information was preferred by 95% but experienced by 68%. Decision Support Tools were preferred by 33% but experienced by 4%. Preferred decisional roles were collaborative (51%), followed by active (26%) and passive (24%), whereas experienced roles were passive (46%), collaborative (31%) and active (23%). Concordance between preferred and experienced roles was 63%. Regression analyses showed associations between decisional roles and country, cancer type, and gender. Respondents from Germany and the UK were more likely to prefer and experience active roles, whereas respondents from Spain and Sweden were more likely to experience passive roles. Female respondents were less likely to prefer an active role. Conclusions: This study highlights gaps between preferences and experiences in European cancer care. Decision-making was generally experienced as more clinician-led than preferred. Improved integration of Decision Support Tools and better alignment of care with patient preferences may enhance SDM.
- 1 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessUnderstanding cancer patients’ preferred and experienced modes of information provision and decisional roles: a cross-sectional questionnaire study in seven European countries
Objectives: Shared Decision Making (SDM) in oncology relies on clear information provision and concordance between patients’ preferred and experienced decisional roles. This study examined preferred and experienced modes of information provision and decisional roles, and assessed whether these varied patients’ by country, cancer type, and sociodemographic characteristics.Methods: A cross-sectional digital survey was conducted among 2,508 respondents with cancer across seven European countries. Modes of information provision were assessed, and decisional roles were measured using the Control Preferences Scale (active, collaborative, passive role). Analyses included chi-square tests, weighted kappa, and multinomial logistic regression.Results: Overall, 69% of respondents reported having been informed about treatment options, ranging from 36% in Sweden to 95% in the UK. Face-to-face information was preferred by 95% but experienced by 68%. Decision Support Tools were preferred by 33% but experienced by 4%. Preferred decisional roles were collaborative (51%), followed by active (26%) and passive (24%), whereas experienced roles were passive (46%), collaborative (31%) and active (23%). Concordance between preferred and experienced roles was 63%. Regression analyses showed associations between decisional roles and country, cancer type, and gender. Respondents from Germany and the UK were more likely to prefer and experience active roles, whereas respondents from Spain and Sweden were more likely to experience passive roles. Female respondents were less likely to prefer an active role. Conclusions: This study highlights gaps between preferences and experiences in European cancer care. Decision-making was generally experienced as more clinician-led than preferred. Improved integration of Decision Support Tools and better alignment of care with patient preferences may enhance SDM.
- Open Access
Experiences with an Advance Care Planning Intervention for Children with Life-Limiting Conditions: A Qualitative Study of Families and Clinicians Using the IMplementing Pediatric Advance Care Planning Toolkit
Background: Advance care planning is a strategy to define goals and preferences for future care and treatment aligned to patient values. The IMplementing Pediatric Advance Care Planning Toolkit (IMPACT) provides a holistic, family-oriented approach to involve families of children with life-limiting conditions and their clinicians in ACP, starting early in disease trajectories. This study explores how children with life-limiting conditions, and their parents and clinicians experience ACP conversations based on IMPACT. Methods: A multicenter, qualitative interview study using inductive thematic analysis was conducted. A total of 27 cases of children with life-limiting conditions were included in the study from February 2019 to December 2019. Interviews with 18 clinicians, 24 mothers, 8 fathers and 3 children were conducted. Results: Clinicians and families of children with life-limiting conditions valued to be involved in ACP conversations based on IMPACT. Although it confronted both parents and clinicians with the impact of caring for a child with a life-limiting condition, sharing the family’s narrative resulted in a stronger relation between families and clinicians. This relation was experienced as a good foundation to share values and preferences for future care and treatment. However, a shared understanding of goals of future care, and treatment based on the conversation was experienced to a limited extent. Conclusions: ACP conversations based on IMPACT facilitated family-centered conversations, and were valued by families of children with life-limiting conditions and their clinicians. The meaning of the family’s narrative in relation to goals and preferences for future care and treatment needs ongoing conversations and coaching on the job of clinicians initiating those conversations.
Open AccessExperiences with an Advance Care Planning Intervention for Children with Life-Limiting Conditions: A Qualitative Study of Families and Clinicians Using the IMplementing Pediatric Advance Care Planning Toolkit
Background: Advance care planning is a strategy to define goals and preferences for future care and treatment aligned to patient values. The IMplementing Pediatric Advance Care Planning Toolkit (IMPACT) provides a holistic, family-oriented approach to involve families of children with life-limiting conditions and their clinicians in ACP, starting early in disease trajectories. This study explores how children with life-limiting conditions, and their parents and clinicians experience ACP conversations based on IMPACT. Methods: A multicenter, qualitative interview study using inductive thematic analysis was conducted. A total of 27 cases of children with life-limiting conditions were included in the study from February 2019 to December 2019. Interviews with 18 clinicians, 24 mothers, 8 fathers and 3 children were conducted. Results: Clinicians and families of children with life-limiting conditions valued to be involved in ACP conversations based on IMPACT. Although it confronted both parents and clinicians with the impact of caring for a child with a life-limiting condition, sharing the family’s narrative resulted in a stronger relation between families and clinicians. This relation was experienced as a good foundation to share values and preferences for future care and treatment. However, a shared understanding of goals of future care, and treatment based on the conversation was experienced to a limited extent. Conclusions: ACP conversations based on IMPACT facilitated family-centered conversations, and were valued by families of children with life-limiting conditions and their clinicians. The meaning of the family’s narrative in relation to goals and preferences for future care and treatment needs ongoing conversations and coaching on the job of clinicians initiating those conversations.
- Open Access
- 4 March 2025
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 8 (1) , e49507
Implementation of a Web-Based Program for Advance Care Planning and Evaluation of its Complexity With the Nonadoption, Abandonment, Scale-Up, Spread, And Sustainability (NASSS) Framework: Qualitative Evaluation Study
Background: The implementation of eHealth applications often fails. The NASSS (nonadoption, abandonment, scale-up, spread, and sustainability) framework aims to identify complexities in eHealth applications; the more complex, the more risk of implementation failure. Objective: This study aimed to analyze the implementation of the web-based advance care planning (ACP) program “Explore Your Preferences for Treatment and Care” using the NASSS framework. Methods: The NASSS framework enables a systematic approach to improve the implementation of eHealth tools. It is aimed at generating a rich and situated analysis of complexities in multiple domains, based on thematic analysis of existing and newly collected data. It also aims at supporting individuals and organizations to handle these complexities. We used 6 of 7 domains of the NASSS framework (ie, condition, technology, value proposition, adopters, external context, and embedding and adaptation over time) leaving out “organization,” and analyzed the multimodal dataset of a web-based ACP program, its development and evaluation, including peer-reviewed publications, notes of stakeholder group meetings, and interviews with stakeholders. Results: This study showed that the web-based ACP program uses straightforward technology, is embedded in a well-established web-based health platform, and in general appears to generate a positive value for stakeholders. A complexity is the rather broad target population of the program. A potential complexity considers the limited insight into the extent to which health care professionals adopt the program. Awareness of the relevance of the web-based ACP program may still be improved among target populations of ACP and among health care professionals. Furthermore, the program may especially appeal to those who value individual autonomy, self-management, and an explicit and direct communicative approach. Conclusions: Relatively few complexities were identified considering the implementation of the web-based ACP program “Explore Your Preferences for Treatment and Care.” The program is evidence-based, freestanding, and well-maintained, with straightforward, well-understood technology. The program is expected to generate a positive value for different stakeholders. Complexities include the broad target population of the program and sociocultural factors. People with limited digital literacy may need support to use the program. Its uptake might be improved by increasing awareness of ACP and the program among a wider population of potential users and among health care professionals. Addressing these issues may guide future use and sustainability of the program.
- 4 March 2025
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 8 (1) , e49507
Open AccessImplementation of a Web-Based Program for Advance Care Planning and Evaluation of its Complexity With the Nonadoption, Abandonment, Scale-Up, Spread, And Sustainability (NASSS) Framework: Qualitative Evaluation Study
Background: The implementation of eHealth applications often fails. The NASSS (nonadoption, abandonment, scale-up, spread, and sustainability) framework aims to identify complexities in eHealth applications; the more complex, the more risk of implementation failure. Objective: This study aimed to analyze the implementation of the web-based advance care planning (ACP) program “Explore Your Preferences for Treatment and Care” using the NASSS framework. Methods: The NASSS framework enables a systematic approach to improve the implementation of eHealth tools. It is aimed at generating a rich and situated analysis of complexities in multiple domains, based on thematic analysis of existing and newly collected data. It also aims at supporting individuals and organizations to handle these complexities. We used 6 of 7 domains of the NASSS framework (ie, condition, technology, value proposition, adopters, external context, and embedding and adaptation over time) leaving out “organization,” and analyzed the multimodal dataset of a web-based ACP program, its development and evaluation, including peer-reviewed publications, notes of stakeholder group meetings, and interviews with stakeholders. Results: This study showed that the web-based ACP program uses straightforward technology, is embedded in a well-established web-based health platform, and in general appears to generate a positive value for stakeholders. A complexity is the rather broad target population of the program. A potential complexity considers the limited insight into the extent to which health care professionals adopt the program. Awareness of the relevance of the web-based ACP program may still be improved among target populations of ACP and among health care professionals. Furthermore, the program may especially appeal to those who value individual autonomy, self-management, and an explicit and direct communicative approach. Conclusions: Relatively few complexities were identified considering the implementation of the web-based ACP program “Explore Your Preferences for Treatment and Care.” The program is evidence-based, freestanding, and well-maintained, with straightforward, well-understood technology. The program is expected to generate a positive value for different stakeholders. Complexities include the broad target population of the program and sociocultural factors. People with limited digital literacy may need support to use the program. Its uptake might be improved by increasing awareness of ACP and the program among a wider population of potential users and among health care professionals. Addressing these issues may guide future use and sustainability of the program.
- Open Access
- 25 November 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1
Correction: “There is a life before and after cancer”: experiences of resuming life and unmet care needs in stage I and II melanoma survivors
- 25 November 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1
Open AccessCorrection: “There is a life before and after cancer”: experiences of resuming life and unmet care needs in stage I and II melanoma survivors
- Top Cited PapersOpen Access
- 10 October 2024
- Published by SAGE Publications in Palliative Medicine
- Vol. 39 (1) , 99-112
Definition and recommendations of advance care planning: A Delphi study in five Asian sectors
Background: In Confucian-influenced Asian societies, explicit end-of-life conversations are uncommon and family involvement in decision-making is crucial, which complicates the adoption of culturally sensitive advance care planning. Aim: To develop a consensus definition of advance care planning and provide recommendations for patient-centered and family-based initiatives in Asia. Design: A five-round Delphi study was performed. The rating of a definition and 84 recommendations developed based on systematic reviews was performed by experts with clinical or research expertise using a 7-point Likert scale. A median = 1 and an inter-quartile range = 0–1 were considered very strong agreement and very strong consensus, respectively. Setting/participants: The Delphi study was carried out by multidisciplinary experts on advance care planning in five Asian sectors (Hong Kong/Japan/Korea/Singapore/Taiwan). Results: Seventy-seven of 115 (67%) experts rated the statements. Advance care planning is defined as “a process that enables individuals to identify their values, to define goals and preferences for future medical treatment and care, to discuss these values, goals, and preferences with family and/or other closely related persons, and health-care providers, and to record and review these preferences if appropriate.” Recommendations in the domains of considerations for a person-centered and family-based approach, as well as elements, roles and tasks, timing for initiative, policy and regulation, and evaluations received high levels of agreement and consensus. Conclusions: Our definition and recommendations can guide practice, education, research, and policy-making in advance care planning for Asian populations. Our findings will aid future research in crafting culturally sensitive advance care planning interventions, ensuring Asians receive value-aligned care.
- 10 October 2024
- Published by SAGE Publications in Palliative Medicine
- Vol. 39 (1) , 99-112
Top Cited PapersOpen AccessDefinition and recommendations of advance care planning: A Delphi study in five Asian sectors
Background: In Confucian-influenced Asian societies, explicit end-of-life conversations are uncommon and family involvement in decision-making is crucial, which complicates the adoption of culturally sensitive advance care planning. Aim: To develop a consensus definition of advance care planning and provide recommendations for patient-centered and family-based initiatives in Asia. Design: A five-round Delphi study was performed. The rating of a definition and 84 recommendations developed based on systematic reviews was performed by experts with clinical or research expertise using a 7-point Likert scale. A median = 1 and an inter-quartile range = 0–1 were considered very strong agreement and very strong consensus, respectively. Setting/participants: The Delphi study was carried out by multidisciplinary experts on advance care planning in five Asian sectors (Hong Kong/Japan/Korea/Singapore/Taiwan). Results: Seventy-seven of 115 (67%) experts rated the statements. Advance care planning is defined as “a process that enables individuals to identify their values, to define goals and preferences for future medical treatment and care, to discuss these values, goals, and preferences with family and/or other closely related persons, and health-care providers, and to record and review these preferences if appropriate.” Recommendations in the domains of considerations for a person-centered and family-based approach, as well as elements, roles and tasks, timing for initiative, policy and regulation, and evaluations received high levels of agreement and consensus. Conclusions: Our definition and recommendations can guide practice, education, research, and policy-making in advance care planning for Asian populations. Our findings will aid future research in crafting culturally sensitive advance care planning interventions, ensuring Asians receive value-aligned care.
- Open Access
- 26 September 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (9) , 1-9
“There is a life before and after cancer”: experiences of resuming life and unmet care needs in stage I and II melanoma survivors
Although the largest increase in melanoma incidence is observed for localised melanoma, little research has been done on its impact. Despite favourable prognoses and relatively short treatment trajectories, diagnosis and treatment may significantly impact life post-treatment. Therefore, the aim of this study was to gain an in-depth understanding of stage I and II melanoma survivors’ experiences resuming life after treatment and their associated survivorship care (SSC) needs. A qualitative focus group study was conducted with 18 stage I or II melanoma survivors, divided over three focus groups with 6 survivors each. Transcripts were analysed through thorough thematic content analysis, using multiple phases of coding. In resuming life, survivors experienced profound initial impacts of disease and treatment, fed by a perceived lack of knowledge and underestimation of melanoma. They faced unexpected physical and emotional effects post-surgery, experiencing mixed feelings from relief to fear and uncertainty. Survivors felt misunderstood, had to adjust their lives, and managed personal and external expectations while experiencing a positive shift in life perspective, leading to a notable difference in life before and after cancer. In terms of SSC needs, survivors stressed the need for tailored information, accessible resources, patient-centered follow-up, and supportive care addressing the total impact of disease and treatment. These findings highlight the importance of improving melanoma awareness and providing holistic SSC not only to advanced, but also to localised melanoma survivors. A tailored survivorship care plan could facilitate access to information and supportive care, helping patients resume their lives.
- 26 September 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (9) , 1-9
Open Access“There is a life before and after cancer”: experiences of resuming life and unmet care needs in stage I and II melanoma survivors
Although the largest increase in melanoma incidence is observed for localised melanoma, little research has been done on its impact. Despite favourable prognoses and relatively short treatment trajectories, diagnosis and treatment may significantly impact life post-treatment. Therefore, the aim of this study was to gain an in-depth understanding of stage I and II melanoma survivors’ experiences resuming life after treatment and their associated survivorship care (SSC) needs. A qualitative focus group study was conducted with 18 stage I or II melanoma survivors, divided over three focus groups with 6 survivors each. Transcripts were analysed through thorough thematic content analysis, using multiple phases of coding. In resuming life, survivors experienced profound initial impacts of disease and treatment, fed by a perceived lack of knowledge and underestimation of melanoma. They faced unexpected physical and emotional effects post-surgery, experiencing mixed feelings from relief to fear and uncertainty. Survivors felt misunderstood, had to adjust their lives, and managed personal and external expectations while experiencing a positive shift in life perspective, leading to a notable difference in life before and after cancer. In terms of SSC needs, survivors stressed the need for tailored information, accessible resources, patient-centered follow-up, and supportive care addressing the total impact of disease and treatment. These findings highlight the importance of improving melanoma awareness and providing holistic SSC not only to advanced, but also to localised melanoma survivors. A tailored survivorship care plan could facilitate access to information and supportive care, helping patients resume their lives.
- Open Access
- 13 May 2024
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 14 (e3) , e2366-e2376
Cancer experience in metaphors: patients, carers, professionals, students – a scoping review
The use of metaphors to talk about cancer experiences has attracted much research and debate, especially in the case of military metaphors. However, questions remain about what metaphors are used by different populations for different aspects of the cancer experience. This scoping review aims to answer them.We searched PubMed, PsycINFO, CINAHL, Scopus and Web of Science databases. Eligible sources include peer-reviewed scientific research published in English between 2013 and 2023, investigating patterns of metaphor use from adult populations (age ≥18) for cancer-related topics, such as cancer itself, the general experience of being ill, treatment, and people and relationships.Out of 1929 articles identified, 30 met the criteria, spanning over different populations. While most papers focused on cancer in general, some focused on specific cancer types, such as breast cancer. Both spontaneous and elicited data were collected in ten languages: mostly English (N=12), Swedish (N=3) and Arabic (N=3). The identified metaphors were subsumed under various broad categories, including particularly violence and journey. Other categories include education and non-human animate entity for the cancer itself, confinement and deprivation and cleanliness for the general experience of being ill with cancer, Poison and gardening for cancer treatment, and distance for patients’ social relationships.It was found that metaphors help to identify how patients describe experiences of vulnerability and empowerment. To provide patient-centred care, clinicians and researchers should avoid blanket conclusions about helpful or unhelpful metaphors, but consider the ways in which different metaphors are used by different populations in different contexts.
- 13 May 2024
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 14 (e3) , e2366-e2376
Open AccessCancer experience in metaphors: patients, carers, professionals, students – a scoping review
The use of metaphors to talk about cancer experiences has attracted much research and debate, especially in the case of military metaphors. However, questions remain about what metaphors are used by different populations for different aspects of the cancer experience. This scoping review aims to answer them.We searched PubMed, PsycINFO, CINAHL, Scopus and Web of Science databases. Eligible sources include peer-reviewed scientific research published in English between 2013 and 2023, investigating patterns of metaphor use from adult populations (age ≥18) for cancer-related topics, such as cancer itself, the general experience of being ill, treatment, and people and relationships.Out of 1929 articles identified, 30 met the criteria, spanning over different populations. While most papers focused on cancer in general, some focused on specific cancer types, such as breast cancer. Both spontaneous and elicited data were collected in ten languages: mostly English (N=12), Swedish (N=3) and Arabic (N=3). The identified metaphors were subsumed under various broad categories, including particularly violence and journey. Other categories include education and non-human animate entity for the cancer itself, confinement and deprivation and cleanliness for the general experience of being ill with cancer, Poison and gardening for cancer treatment, and distance for patients’ social relationships.It was found that metaphors help to identify how patients describe experiences of vulnerability and empowerment. To provide patient-centred care, clinicians and researchers should avoid blanket conclusions about helpful or unhelpful metaphors, but consider the ways in which different metaphors are used by different populations in different contexts.
- Open Access
- 15 April 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Navigating the Complexities of Scaling Remote Patient Management: A Scoping Review (Preprint)
BACKGROUND Large-scale implementation of Remote Patient Management (RPM) promises to improve the overall quality of healthcare. However, innovation often remains on a small and local scale due to complex, multi-faceted challenges during the scaling process of RPM. Overcoming these challenges requires a thorough understanding of the scaling process. The current literature is heterogeneous, and, to our knowledge, there is no comprehensive overview of the multilevel complexity of the scaling process. OBJECTIVE This scoping review examines how the current literature describes the scaling process of RPM, what theoretical frameworks are used and what factors hinder or enable this process. METHODS Following PRISMA-ScR guidelines, a literature search was conducted in the Pubmed and Embase databases. This resulted in the inclusion of 12 studies. Data extraction focused on the characteristics of included studies, terminology of the scaling process, frameworks applied, and factors influencing scaling RPM. RESULTS The included studies exhibited considerable heterogeneity in methodology, focus, and approach to scaling RPM. The terminology used to describe scaling processes varied, reflecting a continuum across the RPM innovation lifecycle. 7 theoretical frameworks were identified that provided mainly descriptive and evaluative insights into the levels of scaling RPM. A total of 568 factors (barriers and enablers) were identified and categorised into 12 thematic clusters. CONCLUSIONS Three sources of complexity in scaling RPM were identified: the process continuum in the terminology used to describe the scaling process; the management of scaling as a multi-levelled process; and the multitude of interconnected categories of factors related to the transition from pilot to scaling. Recommendations for researchers and practitioners are proposed to navigate through these complexities, including clear terminology distinction, development of multi-level process frameworks, holistic assessment of factors, and the creation of integrated overarching scaling strategies. Scaling RPM within healthcare systems presents diverse challenges stemming from the complex nature of the process. Addressing these challenges requires more than “just” implementing in multiple contexts, it requires a strategic approach informed by robust frameworks and actionable recommendations. Future research directions should focus on leveraging knowledge from innovation management to develop effective strategies for scaling RPM in healthcare.
- 15 April 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessNavigating the Complexities of Scaling Remote Patient Management: A Scoping Review (Preprint)
BACKGROUND Large-scale implementation of Remote Patient Management (RPM) promises to improve the overall quality of healthcare. However, innovation often remains on a small and local scale due to complex, multi-faceted challenges during the scaling process of RPM. Overcoming these challenges requires a thorough understanding of the scaling process. The current literature is heterogeneous, and, to our knowledge, there is no comprehensive overview of the multilevel complexity of the scaling process. OBJECTIVE This scoping review examines how the current literature describes the scaling process of RPM, what theoretical frameworks are used and what factors hinder or enable this process. METHODS Following PRISMA-ScR guidelines, a literature search was conducted in the Pubmed and Embase databases. This resulted in the inclusion of 12 studies. Data extraction focused on the characteristics of included studies, terminology of the scaling process, frameworks applied, and factors influencing scaling RPM. RESULTS The included studies exhibited considerable heterogeneity in methodology, focus, and approach to scaling RPM. The terminology used to describe scaling processes varied, reflecting a continuum across the RPM innovation lifecycle. 7 theoretical frameworks were identified that provided mainly descriptive and evaluative insights into the levels of scaling RPM. A total of 568 factors (barriers and enablers) were identified and categorised into 12 thematic clusters. CONCLUSIONS Three sources of complexity in scaling RPM were identified: the process continuum in the terminology used to describe the scaling process; the management of scaling as a multi-levelled process; and the multitude of interconnected categories of factors related to the transition from pilot to scaling. Recommendations for researchers and practitioners are proposed to navigate through these complexities, including clear terminology distinction, development of multi-level process frameworks, holistic assessment of factors, and the creation of integrated overarching scaling strategies. Scaling RPM within healthcare systems presents diverse challenges stemming from the complex nature of the process. Addressing these challenges requires more than “just” implementing in multiple contexts, it requires a strategic approach informed by robust frameworks and actionable recommendations. Future research directions should focus on leveraging knowledge from innovation management to develop effective strategies for scaling RPM in healthcare.
- 1 January 2024
- Published by Springer Nature
- p. 673-687
Self-Management for Patients with Progressive, Life-Threatening Diseases and Their Family Caregivers
- 1 January 2024
- Published by Springer Nature
- p. 673-687
Self-Management for Patients with Progressive, Life-Threatening Diseases and Their Family Caregivers